HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$18.82
Day range
$18.11 - $20.71
Year range
$3.42 - $29.98
Market cap
981.43M USD
Avg Volume
800.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 37.84M | 54.03% |
Operating expense | 53.66M | 5.53% |
Net income | -26.36M | 29.72% |
Net profit margin | -69.68 | 54.37% |
Earnings per share | -0.53 | 33.75% |
EBITDA | -19.04M | 33.64% |
Effective tax rate | 1.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 120.46M | -49.11% |
Total assets | 200.46M | -29.84% |
Total liabilities | 305.93M | 3.88% |
Total equity | -105.47M | — |
Shares outstanding | 48.68M | — |
Price to book | -8.63 | — |
Return on assets | -24.79% | — |
Return on capital | -244.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.36M | 29.72% |
Cash from operations | -38.32M | -181.41% |
Cash from investing | 27.72M | -54.28% |
Cash from financing | 31.32M | 44,007.04% |
Net change in cash | 20.71M | -56.01% |
Free cash flow | -30.56M | -1,990.24% |
About
Founded
2004
Headquarters
Website
Employees
287
